Published in J Neuroinflammation on October 12, 2012
IL-1β associations with posttraumatic epilepsy development: a genetics and biomarker cohort study. Epilepsia (2014) 2.59
Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol (2015) 1.35
Inflammation in neurodegenerative diseases--an update. Immunology (2014) 1.30
Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines. Trends Pharmacol Sci (2015) 1.09
Clinical evidence of inflammation driving secondary brain injury: a systematic review. J Trauma Acute Care Surg (2015) 0.97
Inhibition of cathepsin S produces neuroprotective effects after traumatic brain injury in mice. Mediators Inflamm (2013) 0.92
Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes. J Neurotrauma (2014) 0.91
Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics. Cell Mol Neurobiol (2016) 0.86
Berberine protects against neuronal damage via suppression of glia-mediated inflammation in traumatic brain injury. PLoS One (2014) 0.85
Bridge between neuroimmunity and traumatic brain injury. Curr Pharm Des (2014) 0.84
Traumatic brain injury causes selective, CD74-dependent peripheral lymphocyte activation that exacerbates neurodegeneration. Acta Neuropathol Commun (2014) 0.83
Influence of the extracellular matrix on endogenous and transplanted stem cells after brain damage. Front Cell Neurosci (2014) 0.83
Neuroinflammation in animal models of traumatic brain injury. J Neurosci Methods (2016) 0.83
Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction. J Virol (2014) 0.82
Cerebrospinal Fluid Markers of Macrophage and Lymphocyte Activation After Traumatic Brain Injury in Children. Pediatr Crit Care Med (2015) 0.82
Peripheral Blood Mitochondrial DNA as a Biomarker of Cerebral Mitochondrial Dysfunction following Traumatic Brain Injury in a Porcine Model. PLoS One (2015) 0.81
Motor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189. Int J Mol Sci (2014) 0.81
Emerging Roles for the Immune System in Traumatic Brain Injury. Front Immunol (2016) 0.80
APOE genotype-dependent modulation of astrocyte chemokine CCL3 production. Glia (2014) 0.80
Suppressed cytokine expression immediatey following traumatic brain injury in neonatal rats indicates an expeditious endogenous anti-inflammatory response. Brain Res (2014) 0.80
Ccr2 deletion dissociates cavity size and tau pathology after mild traumatic brain injury. J Neuroinflammation (2015) 0.79
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist. Front Neurosci (2016) 0.78
Recombinant human interleukin-1 receptor antagonist promotes M1 microglia biased cytokines and chemokines following human traumatic brain injury. J Cereb Blood Flow Metab (2015) 0.78
In vivo microdialysis sampling of cytokines from rat hippocampus: comparison of cannula implantation procedures. ACS Chem Neurosci (2013) 0.78
Genome-Wide Changes in Peripheral Gene Expression following Sports-Related Concussion. J Neurotrauma (2016) 0.78
Ventilator-Associated Pneumonia in Pediatric Traumatic Brain Injury. J Neurotrauma (2015) 0.77
Regnase-1 in microglia negatively regulates high mobility group box 1-mediated inflammation and neuronal injury. Sci Rep (2016) 0.76
Impaired Pituitary Axes Following Traumatic Brain Injury. J Clin Med (2015) 0.76
Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration. Sci Rep (2017) 0.76
Multivariate projection method to investigate inflammation associated with secondary insults and outcome after human traumatic brain injury: a pilot study. J Neuroinflammation (2016) 0.76
The p38alpha mitogen-activated protein kinase limits the CNS proinflammatory cytokine response to systemic lipopolysaccharide, potentially through an IL-10 dependent mechanism. J Neuroinflammation (2014) 0.76
Diffuse traumatic brain injury induces prolonged immune dysregulation and potentiates hyperalgesia following a peripheral immune challenge. Mol Pain (2016) 0.76
Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson's Disease. Mediators Inflamm (2017) 0.75
Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents. Mol Neurobiol (2016) 0.75
Older Age Results in Differential Gene Expression after Mild Traumatic Brain Injury and Is Linked to Imaging Differences at Acute Follow-up. Front Aging Neurosci (2016) 0.75
Protective Effects of Calpain Inhibition on Neurovascular Unit Injury through Downregulating Nuclear Factor-κB-related Inflammation during Traumatic Brain Injury in Mice. Chin Med J (Engl) (2017) 0.75
What's new in emergencies, trauma, and shock? Heparin in severe traumatic brain injury: Beyond venous thromboembolism prevention? J Emerg Trauma Shock (2014) 0.75
Differences in the Cellular Response to Acute Spinal Cord Injury between Developing and Mature Rats Highlights the Potential Significance of the Inflammatory Response. Front Cell Neurosci (2017) 0.75
A Three-Day Consecutive Fingolimod Administration Improves Neurological Functions and Modulates Multiple Immune Responses of CCI Mice. Mol Neurobiol (2016) 0.75
Magnetic micelles for DNA delivery to rat brains after mild traumatic brain injury. Nanomedicine (2014) 0.75
A flow cytometric approach to analyzing mature and progenitor endothelial cells following traumatic brain injury. J Neurosci Methods (2016) 0.75
Risk of Coronary Artery Disease in Patients With Traumatic Intracranial Hemorrhage: A Nationwide, Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.75
Lipoic acid treatment after brain injury: study of the glial reaction. Clin Dev Immunol (2013) 0.75
Neuron-specific caveolin-1 overexpression improves motor function and preserves memory in mice subjected to brain trauma. FASEB J (2017) 0.75
Tetramethylpyrazine reduces blood-brain barrier permeability associated with enhancement of peripheral cholinergic anti-inflammatory effects for treating traumatic brain injury. Exp Ther Med (2017) 0.75
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature (1998) 11.41
Diversity of microRNAs in human and chimpanzee brain. Nat Genet (2006) 6.57
White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study. Brain (2007) 4.31
The role of inflammation in CNS injury and disease. Br J Pharmacol (2006) 3.96
The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev (2003) 3.96
Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry (2003) 3.87
Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain (2007) 3.68
Pathophysiology of polytrauma. Injury (2005) 3.33
Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology (1989) 3.24
Pathophysiology of traumatic brain injury. Br J Anaesth (2007) 3.06
Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol (2010) 2.56
Neuronal 'On' and 'Off' signals control microglia. Trends Neurosci (2007) 2.55
Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics (2010) 2.52
Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol (2002) 2.47
beta A4 amyloid protein deposition in brain after head trauma. Lancet (1991) 2.41
The occult aftermath of boxing. J Neurol Neurosurg Psychiatry (1990) 2.41
MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol (2008) 2.39
Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med (2000) 2.38
Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J Exp Med (1990) 2.33
Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry (1994) 2.24
Interleukin-1 immunoreactive innervation of the human hypothalamus. Science (1988) 2.22
The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol (2010) 2.22
Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol (2004) 2.21
Trafficking of immune cells in the central nervous system. J Clin Invest (2010) 2.17
Traumatic brain injury: a disease process, not an event. J Neurotrauma (2010) 2.16
Modulation of immune response by head injury. Injury (2007) 2.16
Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. J Neurobiol (1990) 2.15
Widespread τ and amyloid-β pathology many years after a single traumatic brain injury in humans. Brain Pathol (2011) 2.11
Animal models of head trauma. NeuroRx (2005) 2.09
Chemokine receptors: signposts to brain development and disease. Nat Rev Neurosci (2003) 2.08
Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci (2004) 2.08
Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab (2004) 2.02
The spleen contributes to stroke-induced neurodegeneration. J Neurosci Res (2008) 2.01
Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab (2009) 1.97
Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med (1998) 1.96
Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci (2004) 1.95
Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity (2009) 1.95
Mitochondria, the killer organelles and their weapons. J Cell Physiol (2002) 1.92
Intracranial bone marrow transplantation after traumatic brain injury improving functional outcome in adult rats. J Neurosurg (2001) 1.86
Chemokines: a new class of neuromodulator? Nat Rev Neurosci (2007) 1.76
Involvement of ROS in BBB dysfunction. Free Radic Res (2009) 1.73
Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity--targets--functions. Curr Top Med Chem (2003) 1.70
Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia (2000) 1.70
Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery (2004) 1.68
AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene (2004) 1.68
The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab (2010) 1.67
Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol (1991) 1.63
Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience (2000) 1.61
Altered microRNA expression following traumatic spinal cord injury. Exp Neurol (2009) 1.61
Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell (1991) 1.58
CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci (2004) 1.57
RNA in brain disease: no longer just "the messenger in the middle". J Neuropathol Exp Neurol (2007) 1.57
Traumatic brain injury and Alzheimer's disease: a review. Prog Brain Res (2007) 1.57
Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol (2001) 1.56
Cell death mechanisms and modulation in traumatic brain injury. Neurotherapeutics (2010) 1.54
Inducible nitric oxide synthase and inflammatory diseases. Mol Med (2000) 1.53
Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp Neurol (2009) 1.53
Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J Neurochem (2002) 1.52
Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: association with severity of injury and excitotoxicity. Crit Care Med (2001) 1.52
Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes. J Neurosci Res (2009) 1.48
Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem Res (1998) 1.44
Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab Invest (1996) 1.38
Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J Neurosci (2007) 1.36
HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats. Brain Res (2008) 1.36
Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am J Pathol (2005) 1.35
Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant (2008) 1.34
Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo. J Neurochem (2009) 1.34
Microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury. Brain Res (2009) 1.34
PPAR-gamma agonists as regulators of microglial activation and brain inflammation. Curr Pharm Des (2006) 1.33
Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol (1993) 1.33
Systemic inflammatory response following acute traumatic brain injury. Front Biosci (Landmark Ed) (2009) 1.32
Migration patterns and phenotypic differentiation of long-term expanded human neural progenitor cells after transplantation into the adult rat brain. Brain Res Dev Brain Res (2002) 1.32
Annual review prize lecture cytokines - killers in the brain? J Physiol (1999) 1.31
Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis. Clin Exp Immunol (2001) 1.30
Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. J Neurosci (2005) 1.29
Lipids and lipidomics in brain injury and diseases. AAPS J (2006) 1.27
What has inflammation to do with traumatic brain injury? Childs Nerv Syst (2009) 1.26
Posttraumatic premature Alzheimer's disease. Neuropathologic findings and pathogenetic considerations. Arch Neurol (1982) 1.23
Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor. J Neuroinflammation (2012) 1.22
Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine (1992) 1.22
The pathobiology of moderate diffuse traumatic brain injury as identified using a new experimental model of injury in rats. Neurobiol Dis (2004) 1.21
Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J Neurochem (1999) 1.21
Effect of high-dose dexamethasone on outcome from severe head injury. J Neurosurg (1986) 1.19
Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. J Neuroimmunol (2005) 1.16
Caspase-dependent apoptotic pathways in CNS injury. Mol Neurobiol (2002) 1.16
Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol Neurobiol (2007) 1.15
Axonal injury in the optic nerve: a model simulating diffuse axonal injury in the brain. J Neurosurg (1989) 1.15
Proliferation, migration, and differentiation of human neural stem/progenitor cells after transplantation into a rat model of traumatic brain injury. J Neurosurg (2004) 1.15
A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. Neuroreport (1997) 1.15
Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl- current and chemotaxis in murine microglia. J Immunol (2002) 1.15
The human spleen during physiological stress. Sports Med (2002) 1.14
Immediate splenectomy decreases mortality and improves cognitive function of rats after severe traumatic brain injury. J Trauma (2011) 1.14
(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology. Clin Sci (Lond) (2007) 1.14
Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system. J Neurochem (2011) 1.14
Traumatic brain injury and delayed sequelae: a review--traumatic brain injury and mild traumatic brain injury (concussion) are precursors to later-onset brain disorders, including early-onset dementia. ScientificWorldJournal (2007) 1.13
Post-traumatic Alzheimer's disease: preponderance of a single plaque type. Neuropathol Appl Neurobiol (1991) 1.13
Traumatic brain injury during Operation Iraqi Freedom: findings from the United States Navy-Marine Corps Combat Trauma Registry. J Neurosurg (2008) 1.12
CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J (2003) 1.11
Systemic inflammation exacerbates behavioral and histopathological consequences of isolated traumatic brain injury in rats. Exp Neurol (2008) 1.11
Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med (2004) 2.06
Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir Res (2002) 1.30
Activation of p27Kip1 Expression by E2F1. A negative feedback mechanism. J Biol Chem (2005) 1.23
P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes. Mol Cell Biol (2003) 1.14
Natriuretic peptide receptor a as a novel anticancer target. Cancer Res (2008) 1.14
2'-5' Oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells. J Biol Chem (2002) 1.09
Lateral fluid percussion injury of the brain induces CCL20 inflammatory chemokine expression in rats. J Neuroinflammation (2011) 1.09
Prenatal depression and anxiety in Toxoplasma gondii-positive women. Am J Obstet Gynecol (2011) 1.08
Mitigation of adverse interactions in pairs of clinical practice guidelines using constraint logic programming. J Biomed Inform (2013) 1.05
Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Hum Gene Ther (2002) 1.04
Multifunctional magnetic nanoparticles for targeted delivery. Nanomedicine (2009) 1.03
Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells. J Virol (2011) 1.02
Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides. Nanomedicine (2007) 1.01
ERK-1/2 activity is required for efficient RSV infection. FEBS Lett (2004) 1.01
Chitosan IFN-gamma-pDNA Nanoparticle (CIN) Therapy for Allergic Asthma. Genet Vaccines Ther (2003) 0.99
A 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug development. PLoS One (2013) 0.97
Respiratory syncytial virus infection activates STAT signaling in human epithelial cells. Biochem Biophys Res Commun (2003) 0.96
Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection. PLoS One (2012) 0.94
Dual-purpose magnetic micelles for MRI and gene delivery. J Control Release (2012) 0.93
Mucosal delivery of a double-stapled RSV peptide prevents nasopulmonary infection. J Clin Invest (2014) 0.92
Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor. Genet Vaccines Ther (2008) 0.92
Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm Res (2006) 0.92
Inhibition of p27Kip1 gene transcription by mitogens. Cell Cycle (2009) 0.92
Natriuretic peptide receptor a as a novel target for prostate cancer. Mol Cancer (2011) 0.91
Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling. Hum Gene Ther (2002) 0.91
Nanoparticle-mediated gene delivery: state of the art. Expert Opin Biol Ther (2004) 0.90
Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery. Genet Vaccines Ther (2004) 0.89
Curcumin prevents human dendritic cell response to immune stimulants. Biochem Biophys Res Commun (2008) 0.88
Enhancer of zeste homolog 2 induces pulmonary artery smooth muscle cell proliferation. PLoS One (2012) 0.88
Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice. Virol J (2006) 0.88
Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene. Genet Vaccines Ther (2007) 0.88
Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir Res (2006) 0.87
Ultrasensitive detection of cortisol with enzyme fragment complementation technology using functionalized nanowire. Biosens Bioelectron (2006) 0.86
An immunocompromised BALB/c mouse model for respiratory syncytial virus infection. Virol J (2005) 0.86
Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment. PLoS One (2013) 0.85
Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma. Respir Res (2009) 0.84
Protein kinase C-alpha activity is required for respiratory syncytial virus fusion to human bronchial epithelial cells. J Virol (2004) 0.84
Mechanism of bronchoprotective effects of a novel natriuretic hormone peptide. J Allergy Clin Immunol (2004) 0.83
Serum total IgE and specific IgE to Dermatophagoides pteronyssinus, but not eosinophil cationic protein, are more likely to be elevated in elderly asthmatic patients. Allergy Asthma Proc (2004) 0.82
Atrial natriuretic peptide gene transfer by means of intranasal administration attenuates airway reactivity in a mouse model of allergic sensitization. J Allergy Clin Immunol (2002) 0.82
A chitosan-modified graphene nanogel for noninvasive controlled drug release. Nanomedicine (2013) 0.81
Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity. Int Immunopharmacol (2003) 0.81
Regulating the Regulators: microRNA and Asthma. World Allergy Organ J (2011) 0.80
Chitosan Interferon-gamma Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses. Allergy Asthma Clin Immunol (2008) 0.80
Mite and cockroach proteases activate p44/p42 MAP kinases in human lung epithelial cells. Clin Mol Allergy (2003) 0.80
Natriuretic peptide receptor A signaling regulates stem cell recruitment and angiogenesis: a model to study linkage between inflammation and tumorigenesis. Stem Cells (2013) 0.79
Genetic therapy: on the brink of a new future. Genet Vaccines Ther (2003) 0.78
Nanotechnology Applications to HIV Vaccines and Microbicides. J Glob Infect Dis (2012) 0.78
Chitosan nanoparticle-mediated gene transfer. Methods Mol Biol (2008) 0.78
Pharmacokinetics of polymeric micelles for cancer treatment. Curr Drug Metab (2013) 0.78
Transverse susceptibility as a biosensor for detection of Au-Fe₃O₄ nanoparticle-embedded human embryonic kidney cells. Sensors (Basel) (2013) 0.75
Respiratory syncytial virus: immunopathology and control. Expert Rev Clin Immunol (2006) 0.75
Preparation and Characterization of Molecularly Imprinted Polymeric Nanoparticles for Atrial Natriuretic Peptide (ANP). Adv Funct Mater (2011) 0.75
Modifying allergens and using adjuvants for specific immunotherapy. Clin Allergy Immunol (2004) 0.75
Clinical practice guidelines and comorbid diseases: a MiniZinc representation of guideline models for mitigating adverse interactions. Stud Health Technol Inform (2013) 0.75
Nano/bio interface:impact on drug delivery applications. Drug Deliv Transl Res (2013) 0.75